Andre Jacques Auberton Herve - Jun 9, 2023 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
Director
Signature
/s/ Andre-Jacques Auberton-Herve
Stock symbol
BNKL
Transactions as of
Jun 9, 2023
Transactions value $
$390,000
Form type
4
Date filed
6/21/2023, 10:55 AM
Previous filing
Feb 28, 2022
Next filing
Jun 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock Purchase $390K +650K +237.96% $0.60 923K Jun 9, 2023 Shares held through Star SCI F1
holding BNKL Common Stock 10.7K Jun 9, 2023 Shares held through 4A Consulting and Engineering
holding BNKL Common Stock 95.1K Jun 9, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person acquired the shares of common stock in lieu of cash payment of an aggregate of $390,000 in accrued and unpaid fees relating to reporting person's services as Chairman of the Board of the Issuer.